Biocare launches ‘Temziva’ to defeat Covid-19

by in News August 15, 2021

Last Updates Biocare launches ‘Temziva’ to defeat Covid-19 BIOCARE Lifesciences Inc. (BLI), a Philippine-based pharmaceutical company announced the launch of the first branded generic of tocilizumab (Temziva) 400mg/20ml solution for infusion. Temziva is approved as a Drug Product for Emergency Use Only (DEU). SRS Life Sciences holds the registration for tocilizumab in the Philippines, while […]

Tocilizumab improved survival and clinical outcomes in hospitalised COVID-19 patients

by in News August 15, 2021

Last Updates Tocilizumab improved survival and clinical outcomes in hospitalised COVID-19 patients  Data from RECOVERY trial show tocilizumab improved survival and clinical outcomes in hospitalised COVID-19 patients with hypoxia and systemic inflammation Findings published in The Lancet from the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial showed that treatment with tocilizumab improved survival and other […]

If the conditions for the mass production of Human Influenza Vaccine are met, this can annually prevent $100 M currency expenditure.

by in News August 15, 2021

Last Updates If the conditions for the mass production of Human Influenza Vaccine are met, this can annually prevent $100 M currency expenditure. Mentioning the unveiling of Human Influenza Vaccine, Vice chairman of Alborz Chamber of Commerce stated: if the conditions for the mass production of this product are met, this can annually prevent $100 […]